Moderna

Moderna Deferred Tax Liabilities

The Deferred Tax Liabilities of Moderna (MRNA) as of Nov 20, 2026 is 231.00 M USD.

Deferred Tax Liabilities

231.00 MUSD

Last updated:

Deferred Tax Liabilities of Moderna is 2024 231.00 M USD. Deferred Tax Liabilities of Moderna was 2023 - USD. It decreases by % lower compared to the previous year.

The Moderna Deferred Tax Liabilities history

The Moderna Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
231.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

Deferred Tax Liabilities of Moderna is 231.00 M USD in 2024.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Moderna since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Moderna historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Moderna

All Key Metrics — Moderna